Despite the progress that has been made, a greater focus on resilient and sustainable systems for health (RSSH) will be required in the 2020–2022 allocation period if the Global Fund is to achieve its RSSH-related strategic objectives, the Technical Review Panel (TRP) says in a report released recently on RSSH investments in the
You are here
Funding requests to the Global Fund in next allocation period will need to scale up investments in RSSH, TRP says
The Global Fund has improved its controls, management and oversight of procurement processes at the Secretariat level, in response to issues identified in an audit of procurement and supply chain management carried out in 2015.
The Kenya Medical Supplies Authority (KEMSA) successfully procures and distributes government, Global Fund, and other donor-funded commodities. Prices obtained by KEMSA are competitive compared to prices obtained by the Global Fund’s Pooled Procurement Mechanism (PPM), stock-outs of health commodities occur rarely, if ever, commodities are delivered in a timely fashion, and inventory is properly managed at all stages of the supply chain.
Currency fluctuations are a major concern for Global Fund stakeholders, particularly recipient countries whose domestic currency can experience significant shifts over relatively short periods of time. The strength of both the US dollar and the Euro in recent years has further exacerbated this issue for many countries.
Almost all of the targets for the 2017-2022 Strategic Key Performance Indicator Framework have now been approved, locking in place the full set of targets that the Global Fund will measure its work against for the next few years.
Global Fund’s wambo.org platform has not achieved projected savings, nor improved lead times for orders, OIG says
Although clients using wambo.org express a high degree of satisfaction with the platform, the project has experienced delays, has not achieved projected savings, and has not improved lead times for orders, compared to the Pooled Procurement Mechanism (PPM).
The Global Fund, one of the main purchasers of generic antiretroviral (ARV) medicines for HIV patients in low- and middle-income countries, has dismissed concerns that the limited number of manufacturers tapped to supply these drugs could result in immediate or future shortages. Fund officials said systems are in place to forecast demand, deal with any supply disruptions and increase production to meet future need.
Fin mai 2016, le Fonds mondial a officiellement annoncé le lancement du site wambo.org, une nouvelle plateforme en ligne où les maîtres d’oeuvre des subventions du Fonds vont pouvoir vérifier les prix et commander directeme
At the end of May 2016, the Global Fund formally announced wambo.org, a new online marketplace where implementers of Global Fund grants will be able to check prices and place orders for directly for medicines, other health products and non-health commodities. There are plans to expand the reach of wambo.org even further.